Flucloxacillin

Generic Name: Flucloxacillin

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₉H_₁₇ClFN_₃O_₅S

CAS Number: 5250-39-5

Unique Ingredient Identifier: 43B2M34G2V

Background: Antibiotic analog of cloxacillin.

Indication: Used to treat bacterial infection by susceptible microorganisms.

Associated Conditions: Susceptible infections

Associated Therapies: -

Clinical Trials

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Phase 2

Completed

Conditions: Osteomyelitis

Interventions: Drug: daptomycin
Drug: vancomycin
Drug: teicoplanin
Drug: nafcillin
Drug: oxacillin
Drug: flucloxacillin

First Posted Date: 2007-01-30

Last Posted Date: 2018-01-31

Lead Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Target Recruit Count: 75

Registration Number: NCT00428844

Locations: 🇺🇸
Dartmouth-Hitchcock Medical center, Lebanon, New Hampshire, United States
🇷🇺
Federal Healthcare Institute "Novosibirsk Scientific Research Institute of Traumatology and Orthopedy Rosmeditechnology", Novosibirsk, Russian Federation
🇺🇸
Gundersen Clinic, LTD, La Crosse, Wisconsin, United States

and more 23 locations

Study of Acupuncture and Care Interventions for the Treatment of Breast Inflammation During Breastfeeding

Not Applicable

Completed

Conditions: Mastitis

First Posted Date: 2006-11-29

Last Posted Date: 2006-12-04

Lead Sponsor: Karlstad University

Target Recruit Count: 210

Registration Number: NCT00405158

Locations: 🇸🇪
Dept Obstetrics & Gynecology, Helsingborg Hospital, Helsingborg, Skane, Sweden

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy